Glioblastomas (GBM), another highly lethal CNS cancer, is characterized by aberrant activation of multiple pathways, including the Hedgehog (HH) or MET (also known as c-MET, receptor tyrosine kinase for Hepatocyte Growth Factor (HGF)) signaling [114]. This evidence concerns the gene NTRK1 and glioblastoma.